Surgical Oncology
Volume 19, Issue 2 , Pages 95-105, June 2010

Pelvic reconstruction with a combined hemipelvic prostheses after resection of primary malignant tumor

  • Zheng Guo

      Affiliations

    • Tel.: +86 029 84773411.
    • The authors have contributed equally to this paper and also co-first authors for this article.
  • ,
  • Jing Li

      Affiliations

    • Tel.: +86 029 84771064.
    • The authors have contributed equally to this paper and also co-first authors for this article.
  • ,
  • Guo-Xian Pei
  • ,
  • Xiang-Dong Li
  • ,
  • Zhen Wang

      Affiliations

    • Corresponding Author InformationCorresponding author at: Orthopaedic Department, Xijing Hospital, Changle West Road, Xi'an 710032, PR China. Tel.: +86 029 84775281, 13359265058 (mobile); fax: +86 029 84771064.

The orthopaedic surgery department, Xi Jing Hospital Affiliated to the Fourth Military Medical University, Xi'an, People's Republic of China

Accepted 20 April 2009.

Abstract 

Background

Hemipelvic resections for primary malignant bone tumor require reconstruction to restore weight bearing along anatomic axes. However, reconstruction of the pelvic arch remains a major surgical challenge because of the high rate of associated complications. We designed a combined hemipelvic prosthetic system to reconstruct the pelvis and purpose of this investigation was to assess the oncology and functional outcome and complication rate following this procedures.

Methods

we retrospectively reviewed 18 patients who had primary malignant pelvic tumor resections and reconstructions with the combined hemipelvic prosthesis using pedicle screw-rod constructs augmented with antibiotic cement in combination with a special designed acetabular reinforcement shell and hip prosthesis between 2001 and 2007. Patients were examined clinically and radiographically and were assessed functionally with Musculoskeletal Tumor Society score.

Results

Five (27.8%) patients had type II periacetabular pelvic resection and 5 (27.8%) had types I and II (periacetabular and ilium) pelvic resections. Six (33.3%) patients had types II and III (periacetabular and pubis) pelvic resections, 1 (5.6%) had types I and II and III resections and 1 (5.6%) had a types I and II and IV (periacetabular and ilium and sacrum) resections. Patient survival status, function, and complications were evaluated at a mean following up of 41 months (range, 7–73 months). Ten patients (55.6%) had no evidence of disease, five patients (27.7%) had died from their disease, and three patients (16.7%) were alive with disease. The overall survival rate was 72.2% at 5 years. Local recurrence occurred in four patients (22.2%). Six of 17 patients (35.3%) showed lung metastatic progression. The average MSTS 93 score was 65.5% and 71.7% at three months after surgery and at the last followup. Six (33.3%) patients had surgery-related complications including dislocation in 2, wound dehiscence in 2, deep-vein thrombosis in 1, screw loosening in 1 and sciatic nerve palsy in 1. There was no infection occurred in this series.

Conclusions

Pelvic reconstruction using combined hemipelvic prosthetic system after a limb-salvage resection is an acceptable method because of its lower complication and satisfactory functional outcome and its feasibility of reconstruction for any type of periacetabular tumor resection without elaborate preoperative customize.

Level of evidence

Level IV, therapeutic study.

Keywords: Pelvic, Tumor, Reconstruction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0960-7404(09)00057-7

doi:10.1016/j.suronc.2009.04.003

Surgical Oncology
Volume 19, Issue 2 , Pages 95-105, June 2010